Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Kidney Int. 2019 Mar 4;95(5):1253–1261. doi: 10.1016/j.kint.2018.12.023

Fig. 4.

Fig. 4.

Validation of the polynomial trajectory model in patients from the HALT study. Individual patient data from HALT Study A are represented by straight lines in different colors. The predicted eGFR trajectory for each Irazabal class, using the model developed with the CRISP cohort, is depicted by the superimposed red curved lines.